SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002652
Filing Date
2015-11-13
Accepted
2015-11-13 06:07:52
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20150930x10q.htm 10-Q 2470020
2 EX-31.1 amph-20150930ex311076c13.htm EX-31.1 13404
3 EX-31.2 amph-20150930ex3124401a3.htm EX-31.2 13296
4 EX-32.1 amph-20150930ex3216a5f3e.htm EX-32.1 9976
5 EX-32.2 amph-20150930ex322eb9f39.htm EX-32.2 9912
  Complete submission text file 0001558370-15-002652.txt   10893890

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20150930.xml EX-101.INS 2786701
7 EX-101.SCH amph-20150930.xsd EX-101.SCH 69470
8 EX-101.CAL amph-20150930_cal.xml EX-101.CAL 69861
9 EX-101.DEF amph-20150930_def.xml EX-101.DEF 231538
10 EX-101.LAB amph-20150930_lab.xml EX-101.LAB 508789
11 EX-101.PRE amph-20150930_pre.xml EX-101.PRE 461809
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 151226783
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences